News

Deal Announcements

Kineta Collects New Venture Capital Equity

Tuesday, May 20, 2014 5:45:00 AM PDT | VentureDeal
   Seattle, WA  --  Biotechnology company Kineta has secured $1.6 million in venture capital financing, according to an SEC filing.

Kineta is focused on developing therapeutics automimmune diseases, viral disease and chronic pain.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds purposes.

Kineta is still seeking $8.4 million in additional financing, in minimum increments of $25,000, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1